Tag: Cancer: Uterine
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries
Apart from colorectal cancer, increases in incidence were seen in both younger and older adults
Many Clinicians Not Comfortable With Hormone Therapy in Patients With History of Gynecologic Cancer
Findings show discomfort primarily exists among gynecologists seeing patients with a history of endometrial or epithelial ovarian cancer
Uterine Cancer Incidence, Mortality Expected to Increase Through 2050
Incidence-based mortality projected to be nearly three times higher in Black versus White women
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
Longer mean duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment seen with dostarlimab
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer
Short-term acute toxicity and cancer control outcomes similar to those with standard regimens
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer
Findings seen in combination with chemotherapy following surgery in patients with curative intent
Sacituzumab Govitecan Shows Promise in Advanced Endometrial Cancer
Study reveals objective response rate of 22 percent and clinical benefit rate of 32 percent
Transvaginal Ultrasound Triage Strategy for Endometrial Cancer Not Reliable for Black Women at Risk
Significant proportion of those with EC have endometrial thickness below the range of diagnostic threshold for detection on ultrasound
FDA Approves KEYTRUDA + Chemo for Primary Advanced, Recurrent Endometrial Carcinoma
Significant reductions in disease progression or death seen with both mismatch repair-proficient and -deficient cases
Moderate, Heavy Use of Chemical Hair Relaxer Linked to Uterine Cancer
Among postmenopausal women, moderate and heavy use associated with increased risk versus never/light use












